Sign in

You're signed outSign in or to get full access.

Clay Crolius

Chief Financial Officer at DNA XDNA X
Executive

About Clay Crolius

Clay Crolius is Chief Financial Officer of Sonim Technologies (since July 2022) and previously served as Chief Accounting Officer (Sep 2021–Jul 2022). He holds a BA in Economics and Business from UCLA and is a California CPA; prior roles include finance leadership at Warner Bros. Studios and controller/principal accounting officer roles in technology and manufacturing/retail businesses . As of June 20, 2024 he was 62, and he also serves as Secretary on Company proxy filings . Pay-versus-performance disclosures show cumulative TSR falling to $34.23 for a hypothetical $100 investment in 2024 alongside a net loss of $33.65 million; non-PEO NEO compensation actually paid averaged $513,490 in 2024 . In Q3 2025, Crolius highlighted operational focus on strategic transactions and cost discipline amid reverse split and authorized share increase, noting sequential revenue growth to $16.2 million and improved net loss to $4.8 million .

Past Roles

OrganizationRoleYearsStrategic impact
Sonim TechnologiesChief Accounting OfficerSep 2021–Jul 2022 Finance leadership during transition before CFO appointment
4Front Ventures Corp.Principal Accounting Officer and ControllerDec 2016–Aug 2021 Finance leadership at a national manufacturer and retailer
Ethology CorporationController2015–2016 Controller at digital advertising agency startup
David Lewis CompanySenior Management Consultant2005–2014 Consulting in professional services
Warner Bros. Studios (Time Warner)VP, Financial Operations2000–2005 Financial operations leadership at a major studio

External Roles

No external directorships or board committee roles for Crolius were disclosed in Company filings .

Fixed Compensation

Metric20232024
Base Salary ($)$323,750 $320,000
Actual Bonus Paid ($)$96,000 $93,669
Option Awards (Grant-date Fair Value, $)$157,520 $89,352
Other Compensation ($)
Total ($)$577,270 $503,021
Target Bonus %Not disclosed in DEF 14A Not disclosed in DEF 14A

Notes:

  • Base salary was amended to $320,000 retroactive to Nov 1, 2023 per Crolius Letter Agreement .
  • Sonim, as an emerging growth company, uses scaled executive compensation disclosure; detailed cash/equity mix targets are not provided .

Performance Compensation

Annual/Discretionary Bonus

ElementPolicy2023 Actual2024 Actual
Discretionary/Performance Bonus EligibilityEligible for discretionary and performance-based bonuses payable in cash or equity under the 2019 Plan $96,000 $93,669
Metric, Weighting, Target, Actual, Payout, VestingNot disclosed in proxy (company uses plan metrics but exec-specific scorecards not filed)

Equity Awards and Vesting

Grant DateTypeShares/OptionsExercise Price ($)Vesting ScheduleExpiration
Jan 27, 2023Stock Options10,000 (exercisable) 4.940 Vested; standard post-termination window per plan 1/27/2033
Nov 24, 2023Stock Options20,000 (exercisable) 7.000 One-year vest from grant (special award of 200,000 pre-split → 20,000 post 1-for-10 split) 11/24/2033
Apr 8, 2024Stock Options17,000 (unexercisable) 6.154 Vest in 3 equal annual installments beginning Apr 8, 2025 4/8/2034

Plan-level performance criteria available for PSUs/cash performance awards include financial and operational metrics such as EBITDA, TSR, revenue, margin, ROE/ROA, operating cash flow, market share, cost reduction, and debt reduction; awards may incorporate company-wide or unit-level goals with adjustment provisions . The 2019 Plan prohibits discounted options and single-trigger change-in-control vesting; awards are subject to clawback per Nasdaq Rule 10D-1 .

Equity Ownership & Alignment

Ownership DetailAmountNotes
Total Beneficial Ownership (Shares)66,625 Includes options exercisable within 60 days
% of Shares Outstanding<1% Based on 17,781,919 outstanding shares
Options Exercisable (≤60 days)35,667 From beneficial ownership table
Options – Unexercisable17,000 Apr 8, 2024 grant; vesting begins 2025
RSUs (Vested/Unvested)None disclosed NEO stock awards table shows none outstanding for Crolius
Pledging/HedgingProhibited by Insider Trading Policy (short sales, derivatives, margin, pledges) Aligns with skin-in-the-game
Stock Ownership GuidelinesNot disclosed for executives in proxy General governance and anti-hedging disclosed

Employment Terms

TermKey Provisions
Employment AgreementAmended & restated letter agreement Dec 8, 2023; base salary $320,000 retroactive to Nov 1, 2023; discretionary bonus eligibility; at-will employment
Severance (Change in Control)If terminated without cause or resigned for “good reason” within 12 months post-closing of change in control: lump-sum equal to six months base salary plus guaranteed pro-rated bonus, payable within 30 days
Severance (Non-CIC)Not specifically disclosed for Crolius beyond CIC framework
Equity Acceleration2019 Plan has no automatic single-trigger vesting; Crolius’ agreement does not disclose accelerated vesting terms (Becher has specified acceleration)
ClawbackCompany-wide clawback policy per Nasdaq Rule 10D-1; awards subject to recoupment on restatements
Non-Compete/Non-Solicit/Garden LeaveNot disclosed in proxy filings for Crolius
Tax Gross-upsNot disclosed; no gross-up language in Crolius agreement

Investment Implications

  • Pay-for-performance alignment: Cash compensation is modest with meaningful equity exposure via options; absence of single-trigger acceleration and presence of clawbacks mitigate misalignment risk . However, lack of disclosed bonus scorecards/targets reduces transparency into incentive quality .
  • Selling/vesting pressure: Near-term vesting of the Apr 8, 2024 option grant (first tranche on Apr 8, 2025) and fully vested 2023 special option (post 1-year) create potential event windows; monitor Form 4s around vest dates for selling pressure signals .
  • Retention and change-of-control economics: CIC cash severance at six months salary plus pro-rated bonus is modest; no disclosed equity acceleration reduces CIC windfall risk but may also dampen retention in strategic transactions unless board uses plan discretion .
  • Alignment and risk controls: Strict anti-hedging/pledging policy, clawback compliance, and no discounted options support governance quality; beneficial ownership is small (<1%), typical for micro-cap EGCs, but option holdings provide upside alignment .
  • Company backdrop: Reverse split (1-for-18) and authorized share increase executed in Oct 2025 to regain Nasdaq compliance and pursue capital flexibility; CFO commentary emphasizes strategic monetization of listing, suggesting elevated corporate action probability and potential executive retention stress in volatile periods .